<DOC>
	<DOCNO>NCT01090622</DOCNO>
	<brief_summary>The purpose study determine whether XPF-001 safe effective treatment pain cause Inherited Erythromelalgia ( IEM ) .</brief_summary>
	<brief_title>Study XPF-001 Treatment Pain From Primary/Inherited Erythromelalgia ( IEM )</brief_title>
	<detailed_description />
	<mesh_term>Erythromelalgia</mesh_term>
	<criteria>The study require : Be1875 year old Have inherit erythromelalgia Be experience pain cause erythromelalgia ( Moderate pain score 4/10 ) Be generally healthy ( apart pain ) Stop take usual pain medication 9 day Not pregnant breastfeed Your role study include : An outpatient screening visit 9days/8 nightsinpatient treatment visit Nijmegen Medical Center ( closely monitor ) A follow phone call ( return home ) Taking investigational medication daily Recording pain level daily stay Medical Center . Coexistent source pain condition Receiving professional psychological support deal IEM Treatment significant depression within 6 month screen Active HIV , Hepatitis B C Use prescription OTC medication checkin discharge Women pregnant , lactate Not currently use adequate contraception Alcoholism alcohol substance abuse Presence history major psychiatric disturbance Unwilling unable comply dietary activity restriction Any condition finding may pose undue risk participation Use investigational drug 60 day prior dose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>